Sugammadex Injection (Bridion)- Multum

Sugammadex Injection (Bridion)- Multum тож обязательно

имеются? Sugammadex Injection (Bridion)- Multum раз тему

The corresponding author must indicate clearly what alterations have been made in response to the referee's comments point by point. Acceptable reasons should be given for noncompliance with any recommendation of the referees. Manuscripts written by authors who are Sugammadex Injection (Bridion)- Multum of proper English usage should be checked by someone proficient in the English language before submitting.

Manuscripts failing to meet the standards, poorly Sugammadex Injection (Bridion)- Multum or formatted are editorially rejected without further review. Galley proofs in PDF format for an logo sanofi article will be sent by e-mail to the corresponding author for the correction of any editorial errors, not for addition of new material or revision of the text.

Excessive alteration of an article is not allowed during galley proof reading. The proofs should be corrected and mailed to the Http:// Office within 72 h.

The publication charge is 1,000 US dollars (or 1,000,000 Korean Won) per article for Korean Society for Food Science of Animal Resources (KoSFA) members and 1,200 US dollars (or 1,200,000 Korean Won) for non-members. First and corresponding authors should pay membership fee to KoSFA.

The publication charge for a corresponding author outside Korea is 500 US dollars per article. Additionally, 100 US dollars (or 100,000 Sugammadex Injection (Bridion)- Multum Won) will be charged for color print per page for all authors.

Invited review is exempt from page charges. Reprints will be provided upon request. Sugammadex Injection (Bridion)- Multum will cost 50 US dollars (or 50,000 Korean Won) for 20 copies.

The corresponding author is responsible for signing a Sugammadex Injection (Bridion)- Multum transfer agreement on behalf of all authors. Sugammadex Injection (Bridion)- Multum agreement form is sent to the corresponding author Sugammadex Injection (Bridion)- Multum the manuscript is accepted and Kesimpta (Ofatumumab FDA for publication.

In principle, the first and corresponding authors should be member of the KoSFA for submission and consideration of manuscripts. It is important that the files should be submitted as a format of the word document (. Manuscripts should be typed double spaced within 2. The font size should be no smaller than 12 points and Times New Roman font is preferred. Every page of the manuscript should be page and line numbered. Lines must be numbered consecutively throughout the manuscript, not per page.

The title page file and manuscript file should be uploaded separately. The title page file should be included:Place an asterisk after the name of the corresponding author.

The affiliation address for each author except the first and corresponding authors should be indicated by superscript Arabic numbers (1, 2, 3, etc). It must include the abstract, main text, references, and figure legends followed by tables and figures in a Sugammadex Injection (Bridion)- Multum word file for initial submission.

Each figure should be labeled with a figure number. Figures can be uploaded in a separate file if it is necessary. Articles reports of original, scientifically sound research.

Articles should be structured under the section headings Introduction, Materials and Methods, Results, Discussion, Acknowledgment(s), and References. The standard length of a published Article should be six printed pages long including tables and figures, which is approximately the equivalent of a Word document of A4 pages of double-spaced 12 pt Times New Roman font. Short Communications are short reports Sugammadex Injection (Bridion)- Multum the rapid presentation of new observation.



04.05.2020 in 13:25 sadextcomplan:
Почему у вашего ресурса такой маленький тиц?